A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice

Aims: Pharmacological blockade of mineralocorticoid receptors (MRs) is a potential therapeutic approach to reduce cardiovascular complications since MRs play a crucial role in cardiovascular regulation. Recent studies suggest that MR antagonists affect several extrarenal tissues, including vessel fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Munkhjargal, Uugantsetseg, Fukuda, Daiju, Ganbaatar, Byambasuren, Suto, Kumiko, Matsuura, Tomomi, Ise, Takayuki, Kusunose, Kenya, Yamaguchi, Koji, Yagi, Shusuke, Yamada, Hirotsugu, Soeki, Takeshi, Wakatsuki, Tetsuzo, Sata, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067342/
https://www.ncbi.nlm.nih.gov/pubmed/35732424
http://dx.doi.org/10.5551/jat.63382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067342/
https://www.ncbi.nlm.nih.gov/pubmed/35732424
http://dx.doi.org/10.5551/jat.63382

Ejemplares similares